A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics
Shirahata, A., Fukutake, K., Takamatsu, J., Shima, M., Hanabusa, H., Mugishima, H., Amano, K., Takedani, H., Tamashima, S., Matsushita, T., Tawa, A., Tanaka, I., Higasa, S., Kosaka, Y., Fujii, T., SakVolume:
19
Language:
english
Journal:
Haemophilia
DOI:
10.1111/hae.12205
Date:
November, 2013
File:
PDF, 308 KB
english, 2013